Seite - 141 - in Advances in Neuroimmunology

BrainSci. 2017,7, 11 56. Petraglia,A.L.;Plog,B.A.;Dayawansa,S.;Chen,M.;Dashnaw,M.L.;Czerniecka,K.;Walker,C.T.;Viterise,T.; Hyrien,O.; Iliff, J.J.; etal. Thespectrumofneurobehavioral sequelaeafter repetitivemildtraumaticbrain injury: Anovelmousemodel of chronic traumatic encephalopathy. J.Neurotrauma 2014, 31, 1211–1224. [CrossRef] [PubMed] 57. Fox,G.B.;Fan,L.;Levasseur,R.A.;Faden,A.I.Sustainedsensory/motorandcognitivedeficitswithneuronal apoptosis followingcontrolledcortical impactbrain injury in themouse. J.Neurotrauma1998,15, 599–614. [CrossRef] [PubMed] 58. Washington,P.M.;Forcelli,P.A.;Wilkins,T.;Zapple,D.N.;Parsadanian,M.;Burns,M.P.Theeffectof injury severityonbehavior: Aphenotypic studyof cognitiveandemotionaldeficits aftermild,moderate, and severecontrolledcortical impact injury inmice. J.Neurotrauma2012,29, 2283–2296. [CrossRef] [PubMed] 59. Marklund,N.;Hillered,L.Animalmodellingof traumaticbrain injury inpreclinicaldrugdevelopment: Wheredowegofromhere?Br. J.Pharmacol. 2011,164, 1207–1229. [CrossRef] [PubMed] 60. Dixon, C.E.; Kraus, M.F.; Kline, A.E.; Ma, X.; Yan, H.Q.; Griffith, R.G.; Wolfson, B.M.; Marion, D.W. Amantadine improveswatermaze performancewithout affectingmotor behavior following traumatic brain injury inrats.Restor.Neurol.Neurosci. 1999,14, 285–294. [PubMed] 61. Dixon,C.E.;Kochanek,P.M.;Yan,H.Q.;Schiding, J.K.;Griffith,R.G.;Baum,E.;Marion,D.W.;DeKosky,S.T. One-yearstudyofspatialmemoryperformance,brainmorphology,andcholinergicmarkersaftermoderate controlledcortical impact inrats. J.Neurotrauma1999,16, 109–122. [CrossRef] [PubMed] 62. Masel,B.E.;DeWitt,D.S.Traumaticbrain injury:Adiseaseprocess,notanevent. J.Neurotrauma2010,27, 1529–1540. [CrossRef] [PubMed] 63. Davis,A.E.Mechanismsof traumaticbrain injury: Biomechanical, structuralandcellularconsiderations. Crit. CareNurs.Q.2000,23, 1–13. [CrossRef] [PubMed] 64. Gaetz,M.Theneurophysiologyofbrain injury.Clin.Neurophysiol. 2004,115, 4–18. [CrossRef] 65. Cernak, I.Animalmodelsofheadtrauma.NeuroRx2005,2, 410–422. [CrossRef] [PubMed] 66. Bramlett,H.M.;Dietrich,W.D.Progressivedamageafterbrainandspinalcord injury: Pathomechanismsand treatmentstrategies.Prog. BrainRes. 2007,161, 125–141. [PubMed] 67. Marklund,N.; Bakshi, A.; Castelbuono, D.J.; Conte, V.; McIntosh, T.K. Evaluation of pharmacological treatmentstrategies in traumaticbrain injury.Curr. Pharm.Des. 2006,12, 1645–1680. [CrossRef] [PubMed] 68. Povlishock, J.T.;Christman,C.W.Thepathobiologyof traumatically inducedaxonal injury inanimalsand humans:Areviewofcurrent thoughts. J.Neurotrauma1995,12, 555–564. [CrossRef] [PubMed] 69. Arvin,B.;Neville,L.F.;Barone,F.C.;Feuerstein,G.Z.Brain injuryandinflammation.AputativeroleofTNF alpha.Ann.N.Y.Acad. Sci. 1995,765, 62–71. [CrossRef] [PubMed] 70. Isaksson, J.;Lewen,A.;Hillered,L.;Olsson,Y.Up-regulationof intercellularadhesionmolecule1 incerebral microvesselsafter cortical contusion traumainaratmodel.ActaNeuropathol. 1997,94, 16–20. [CrossRef] [PubMed] 71. Yang,K.;Mu,X.S.;Xue, J.J.;Whitson, J.; Salminen,A.;dixon,C.E.;Liu,P.K.;Hayes,R.L. Increasedexpression of c-fosmRNAandAP-1 transcription factors after cortical impact injury in rats. BrainRes. 1994, 664, 141–147. [CrossRef] 72. Yatsiv, I.; Morganti-Kossmann,M.C.; Perez, D.; Dinarello, C.A.; Novick, D.; Rubinstein,M.; Otto, V.I.; Rancan,M.; Kossmann, T.; Redaelli, C.A.; et al. Elevated intracranial IL-18 in humans andmice after traumaticbrain injuryandevidenceofneuroprotectiveeffectsof IL-18-bindingproteinafterexperimental closedheadinjury. J.Cereb. BloodFlowMetab. 2002,22, 971–978. [CrossRef] [PubMed] 73. Hutchinson, P.J.; O’Connell,M.T.; Rothwell,N.J.; Hopkins, S.J.; Nortje, J.; Carpenter, K.L.; Timofeev, I.; Al-Rawi,P.G.;Menon,D.K.;Pickard, J.D. Inflammation inhumanbrain injury: Intracerebral concentrations of IL-1alpha, IL-1beta,andtheirendogenous inhibitor IL-1ra. J.Neurotrauma2007,24, 1545–1557. [CrossRef] [PubMed] 74. Utagawa,A.;Truettner, J.S.;Dietrich,W.D.;Bramlett,H.M.Systemic inflammationexacerbatesbehavioral andhistopathologicalconsequencesof isolatedtraumaticbrain injury inrats.Exp.Neurol. 2008,211, 283–291. [CrossRef] [PubMed] 75. Minami,M.;Kuraishi,Y.;Satoh,M.EffectsofkainicacidonmessengerRNAlevelsof IL-1beta, IL-6,TNF alphaandlif in theratbrain.Biochem.Biophys. Res. Commun. 1991,176, 593–598. [CrossRef] 76. Liu,T.;Clark,R.K.;McDonnell,P.C.;Young,P.R.;White,R.F.;Barone,F.C.;Feuerstein,G.Z.Tumornecrosis factor-alphaexpression in ischemicneurons.Stroke1994,25, 1481–1488. [CrossRef] [PubMed] 141